Application of miR-132 in preparation of drugs for addiction treatment

A 1.mir-132, drug technology, applied in the field of molecular biology and medicine, can solve problems such as normal biological influence amplification

Inactive Publication Date: 2019-09-06
SHENZHEN KANGNING HOSPITAL SHENZHEN MENTAL HEALTH INST SHENZHEN MENTAL HEALTH CENT
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Normal biological effects of DA ar

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of miR-132 in preparation of drugs for addiction treatment
  • Application of miR-132 in preparation of drugs for addiction treatment
  • Application of miR-132 in preparation of drugs for addiction treatment

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0033] The principles and features of the present invention are described below in conjunction with the accompanying drawings, and the examples given are only used to explain the present invention, and are not intended to limit the scope of the present invention. Definition of nouns:

[0034] 1) miRNA enhancer: a nucleic acid substance that increases the amount of corresponding miRNA in cells, such as miRNA mimics, strong promoter-driven miRNA expression vectors, etc.

[0035] 2) miRNA weakening substances: nucleic acid substances that reduce the amount of corresponding miRNA in cells, such as miRNA inhibitors, miRNA-sponge, etc.

[0036] 3) miRNA-sponge: a single-stranded RNA with multiple tandem repeats, each repeating unit has a complementary sequence to all or part of the corresponding miRNA sequence, so it can bind and absorb the corresponding miRNA, reducing the effective concentration of the miRNA in the cell .

[0037] 1. Research on SLC6A3 mRNA 3'UTR

[0038] We ca...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to non-therapeutic application of miR-132 in regulating DAT (dopamine active transporter) gene expression in cells and also relates to a non-therapeutic application to regulate DAT gene expression in cells. The non-therapeutic method includes increasing or decreasing quantity of miR-132 in cells. The invention also relates to application of miR-132, miR-132 reinforcer or miR-132 weakener in the preparation of drugs to regulate cellular intake of dopamine, and also relates to application of miR-132, miR-132 reinforcer or miR-132 weakener in the preparation of drugs to treat psychoactive drug substances.

Description

technical field [0001] The invention relates to the fields of molecular biology and medicine. More particularly, it relates to the use of miR-132 in the preparation of medicaments for the treatment of addiction to psychoactive substances. Background technique [0002] Psychoactive substance addiction is a disorder of brain function caused by the use of psychoactive substances that makes it impossible for a person to control their use. Addiction to psychoactive substances is a chronic relapsing disorder usually accompanied by additional psychological or physical symptoms, typically symptoms such as involuntary drug use and withdrawal syndrome. [0003] The neurotransmitter dopamine (DA) controls a variety of functions, including motor, cognition, emotion and reward. A large amount of neuropharmacological evidence in humans and animals shows that the DA system plays an important role in the three stages of the addiction cycle (euphoria, withdrawal, and craving). It is a nor...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/7105A61P25/30A61P25/36
CPCA61K31/7105A61P25/30A61P25/36
Inventor 贾晓健荣晗杨梅刘慧铭刘铁榜
Owner SHENZHEN KANGNING HOSPITAL SHENZHEN MENTAL HEALTH INST SHENZHEN MENTAL HEALTH CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products